Noninvasive Prenatal Testing (NIPT) Detects More Than 80 Percent Of Chromosomal Abnormalities, University of California, San Francisco (UCSF) Study

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

In a study to be presented on Feb. 6 at 9 a.m. CST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting™, in New Orleans, researchers will report that noninvasive prenatal testing detected 83.2 percent of chromosomal abnormalities normally picked up by invasive diagnostic testing strategies, such as chorionic villus sampling (CVS) or amniocentesis. Noninvasive prenatal testing (NIPT) using cell free DNA provides accurate screening for the common trisomies, including trisomy 13 (Patau syndrome), 18 (Edwards syndrome), and 21 (Down syndrome).

Hey, check out all the engineering jobs. Post your resume today!

Back to news